EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sequential Field Therapy in Actinic Keratosis: A Mechanism-Based Rationale for Complementary Treatment Strategies

Giulio Gualdi iD, Gabriele Soligon, Patrick Silvetti iD, Leonardo Balestra iD, Davide Bertolla iD, Luca Fania, Francesco Ricci iD, Mario Puviani iD, Paolo Sbano, Andrea Paradisi

Journal of Clinical Medicine · 11.06.2026 · 15 (12) · 4553

DOI: 10.3390/jcm15124553 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.06.2026. Verfasst von Giulio Gualdi und 9 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital, Ospedale Maggiore di Parma, 43126 Parma, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Actinic keratoses are common keratinocytic precursor lesions arising within chronically ultraviolet-damaged skin and are associated with an increased risk of progression to cutaneous squamous cell carcinoma. The concept of field cancerization has shifted therapeutic strategies from the treatment of isolated visible lesions toward broader field-directed approaches targeting both clinical and subclinical disease.

Methods

This narrative review summarizes the rationale, mechanisms of action, efficacy profile, tolerability, and practical limitations of currently available field-directed therapies for actinic keratosis, including 5-fluorouracil, imiquimod, diclofenac, photodynamic therapy, and tirbanibulin. Based on their distinct biological targets, we propose a mechanism-based framework for sequential treatment strategies.

Results

Available therapies act through partially non-overlapping mechanisms, including cytotoxic activity, immune activation, cyclooxygenase-2 inhibition, photodynamic oxidative damage, and tubulin/Src pathway inhibition. These complementary effects provide a biological rationale for sequential regimens aimed at addressing the heterogeneity of field cancerization. However, direct clinical evidence supporting specific treatment sequences remains limited, and proposed regimens should be interpreted as hypothesis-generating rather than as validated therapeutic protocols.

Conclusions

Mechanism-based sequential field therapy may represent a rational strategy to optimize long-term control of actinic keratosis and field cancerization. Prospective comparative studies are needed to define optimal sequences, treatment intervals, patient selection criteria, and clinically meaningful endpoints, including sustained field clearance, recurrence reduction, tolerability, adherence, and prevention of progression to invasive cutaneous squamous cell carcinoma.

Schlagwörter

Stichwörter der Autor:innen

5-fluorouracilactinic keratosisdiclofenacfield cancerizationimiquimodphotodynamic therapysequential treatmenttirbanibulin

Autor:innen und Institutionen

  • University Hospital, Ospedale Maggiore di Parma, 43126 Parma, Italy.
  • Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.
  • Skin Cancer Center, Istituto Dermopatico dell'Immacolata-IRCCS, 00167 Rome, Italy.
  • Department of Life Science, Health, and Health Professions, Link University of Rome, 00168 Rome, Italy.
  • Dermatology Clinic, Sassuolo Hospital, 41049 Sassuolo, Italy.
  • Dermatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy.

ORCID-Profile: Giulio Gualdi, Patrick Silvetti, Leonardo Balestra, Davide Bertolla, Francesco Ricci, Mario Puviani

Zitieren

APA

Gualdi, G., Soligon, G., Silvetti, P., Balestra, L., Bertolla, D., Fania, L., Ricci, F., Puviani, M., Sbano, P., & Paradisi, A. (2026). Sequential Field Therapy in Actinic Keratosis: A Mechanism-Based Rationale for Complementary Treatment Strategies. Journal of Clinical Medicine, 15(12), 4553. https://doi.org/10.3390/jcm15124553

Vancouver

Gualdi G, Soligon G, Silvetti P, Balestra L, Bertolla D, Fania L, et al. Sequential Field Therapy in Actinic Keratosis: A Mechanism-Based Rationale for Complementary Treatment Strategies. Journal of Clinical Medicine. 2026;15(12):4553. doi:10.3390/jcm15124553

BibTeX
@article{Gualdi2026,
  author = {Gualdi, Giulio and Soligon, Gabriele and Silvetti, Patrick and Balestra, Leonardo and Bertolla, Davide and Fania, Luca and Ricci, Francesco and Puviani, Mario and Sbano, Paolo and Paradisi, Andrea},
  title = {Sequential Field Therapy in Actinic Keratosis: A Mechanism-Based Rationale for Complementary Treatment Strategies},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {12},
  pages = {4553},
  doi = {10.3390/jcm15124553}
}
Kostenlos starten →